Latest news with #SafexChemicals
&w=3840&q=100)
Business Standard
07-07-2025
- Business
- Business Standard
Safex Chemicals files DRHP, aims to raise ₹450 crore for debt reduction
Safex Chemicals IPO plans: Delhi-based Safex Chemicals, a speciality chemicals company with a focus on agrochemicals, has filed its draft red herring prospectus (DRHP) with the Securities and Exchange Board of India (Sebi). The initial public offering (IPO) comprises a combination of a fresh issue of face value of ₹1 per share aggregating up to ₹450 crore and an offer for sale (OFS) of up to 35.73 million equity shares. The promoters and investors selling shareholders include Surinder Kumar Chaudhary, Rajesh Kumar Jindal, Neeraj Kumar Jindal, Piyush Jindal, Sarcoline, Anchor Partners, and Sage Investment Trust. The company has reserved not more than 50 per cent of the issue for qualified institutional buyers, not less than 15 per cent for non-institutional investors (NIIs) and 35 per cent for retail investors. KFin Technologies is the registrar of the issue. Axis Capital, JM Financial and SBI Capital Markets are the book-running lead managers. According to the DRHP, the company proposes to utilise ₹255.59 crore from the net fresh issue proceeds for repayment or prepayment, in part or full, of certain of or all of borrowings availed by the company and ₹110 crore for repayment/prepayment, in part or full, of certain of or all of borrowings availed by its subsidiary, Shogun Organics, through investments in such subsidiary. The remaining funds will be used for general corporate purposes. The company might consider a pre-IPO placement of ₹90 crore. "If such placement is completed, the fresh issue size will be reduced. The pre-IPO placement, if undertaken, shall not exceed 20 per cent of the size of the fresh issue," as per the DRHP. Check Crizac IPO allotment status About Safex Chemicals Incorporated in 1991, Safex Chemicals operates in three business verticals, including branded formulations, speciality chemicals and contract development and manufacturing (CDMO), catering to the needs of farmers and global agrochemical companies. In a series of acquisitions, the company acquired Shogun Lifesciences in July 2021, Shogun Organics in September 2021 and Briar Chemicals in the United Kingdom in October 2022. As of March 31, 2025, its operations are spread across 22 countries in six continents. In FY25, the company reported revenue from operations of ₹1,584.7 crore, up 12.83 per cent from ₹1,404.59 crore in the previous fiscal.
Mint
06-07-2025
- Business
- Mint
Safex Chemicals IPO: Speciality chemicals firm files DRHP with SEBI for ₹450 crore IPO
Safex Chemicals is in the process of bringing its initial public offering (IPO) of ₹ 450 crore in the near future. The speciality chemicals company has filed a Draft Red Herring Prospectus (DRHP) with the capital markets regulator, Securities and Exchange Board of India (SEBI), to bring the issue, which combines a fresh issue of ₹ 450 crore and an offer for sale (OFS) up to 3,57,34,818 shares. The offer also includes a subscription reservation by eligible employees in the employee reservation portion. The offer is being made through the book-building process, wherein not more than 50 per cent of the offer is allocated to qualified institutional buyers, and not less than 15 per cent and 35 per cent of the offer is assigned to non-institutional and retail individual bidders, respectively. According to the company, the proceeds from the fresh issue to the extent of ₹ 255.59 crore will be used for the repayment or prepayment of certain or all of the borrowings availed by it. Besides, about ₹ 110 crore of the proceeds will be used to repay or prepay certain or all of the borrowings taken out by its subsidiary, Shogun Organics. Some parts of the net proceeds will be used for general corporate purposes. Axis Capital Limited, JM Financial Limited and SBI Capital Markets Limited are the book-running lead managers of the issue, while KFin Technologies is the registrar to the offer. Incorporated in 1991, Safex Chemicals is a specialty chemicals company with a focus on agrochemicals. It operates in branded formulation, speciality chemicals and contract development and manufacturing (CDM') verticals, catering to the needs of farmers and global agrochemical companies. For the financial year 2022-23 (FY23), the company's revenue from operations stood at ₹ 1,161.02 crore, which rose to ₹ 1,404.59 crore in FY24 and ₹ 1,584.78 crore in FY25. However, the company has been incurring losses in the last three financial years. In FY23, it suffered a loss of ₹ 1.02 crore, in FY24 ₹ 22.79 crore and in FY25 ₹ 14.29 crore. EBITDA for FY23, FY24 and FY25 stood at ₹ 149.06 crore, ₹ 118.65 crore and ₹ 233.03 crore, respectively. EBITDA margin for FY23, FY24 and FY25 stood at 12.84 per cent, 8.45 per cent and 14.70 per cent, respectively. Read all IPO-related news here Disclaimer: This story is for educational purposes only. The views and recommendations expressed are those of individual analysts or broking firms, not Mint. We advise investors to consult with certified experts before making any investment decisions, as market conditions can change rapidly and circumstances may vary.
Mint
06-07-2025
- Business
- Mint
Safex Chemicals IPO: Speciality chemicals firm files DRHP with SEBI for ₹450 crore IPO
Safex Chemicals is in the process of bringing its initial public offering (IPO) of ₹ 450 crore in the near future. The speciality chemicals company has filed a Draft Red Herring Prospectus (DRHP) with the capital markets regulator, Securities and Exchange Board of India (SEBI), to bring the issue, which combines a fresh issue of ₹ 450 crore and an offer for sale (OFS) up to 3,57,34,818 shares. The offer also includes a subscription reservation by eligible employees in the employee reservation portion. The offer is being made through the book-building process, wherein not more than 50 per cent of the offer is allocated to qualified institutional buyers, and not less than 15 per cent and 35 per cent of the offer is assigned to non-institutional and retail individual bidders, respectively. According to the company, the proceeds from the fresh issue to the extent of ₹ 255.59 crore will be used for the repayment or prepayment of certain or all of the borrowings availed by it. Besides, about ₹ 110 crore of the proceeds will be used to repay or prepay certain or all of the borrowings taken out by its subsidiary, Shogun Organics. Some parts of the net proceeds will be used for general corporate purposes. Axis Capital Limited, JM Financial Limited and SBI Capital Markets Limited are the book-running lead managers of the issue, while KFin Technologies is the registrar to the offer. Incorporated in 1991, Safex Chemicals is a specialty chemicals company with a focus on agrochemicals. It operates in branded formulation, speciality chemicals and contract development and manufacturing (CDM') verticals, catering to the needs of farmers and global agrochemical companies. For the financial year 2022-23 (FY23), the company's revenue from operations stood at ₹ 1,161.02 crore, which rose to ₹ 1,404.59 crore in FY24 and ₹ 1,584.78 crore in FY25. However, the company has been incurring losses in the last three financial years. In FY23, it suffered a loss of ₹ 1.02 crore, in FY24 ₹ 22.79 crore and in FY25 ₹ 14.29 crore. EBITDA for FY23, FY24 and FY25 stood at ₹ 149.06 crore, ₹ 118.65 crore and ₹ 233.03 crore, respectively. EBITDA margin for FY23, FY24 and FY25 stood at 12.84 per cent, 8.45 per cent and 14.70 per cent, respectively. Read all IPO-related news here
Economic Times
05-07-2025
- Business
- Economic Times
Safex Chemicals files IPO papers; eyes Rs 450 cr via fresh issue
Speciality chemicals company Safex Chemicals (India) has filed preliminary papers with the capital markets regulator Sebi to seek approval to raise funds through an initial public offering (IPO). ADVERTISEMENT The IPO is a mix of fresh issue of shares worth Rs 450 crore and an offer-for-sale of 35,734,818 shares by promoters, investors and other selling shareholders, according to the draft red herring prospectus (DRHP) filed on Thursday. Proceeds from the fresh issue will be used for debt payment and general corporate purposes. Chrys Capital had invested in the company in March 2021 and September 2022, and owns 44.80 per cent of the equity share capital. Safex Chemicals may consider raising Rs 90 crore in a pre-IPO placement. If such placement is completed, the fresh issue size will be reduced. Incorporated in 1991, Safex Chemicals (India) operates in three business verticals --- branded formulations, speciality chemicals and contract development and manufacturing (CDMO). It serves farmers to help increase crop productivity by providing a wide range of crop protection products. ADVERTISEMENT The company has undertaken a series of acquisitions, as it bought Shogun Lifesciences in July 2021, Shogun Organics in September 2021 and Briar Chemicals in the UK in October of March 31, 2025, the company had operations spread across 22 countries. It has seven manufacturing units in India and one in the United Kingdom. ADVERTISEMENT Safex Chemicals' revenue from operations increased by 12.83 per cent to Rs 1,584.78 crore in fiscal 2025 from Rs 1,404.59 crore in the preceding fiscal. Axis Capital, JM Financial and SBI Capital Markets are the book-running lead managers to the issue. Equity shares are proposed to be listed on the NSE and BSE. PTI (You can now subscribe to our ETMarkets WhatsApp channel)
Time of India
05-07-2025
- Business
- Time of India
Safex Chemicals files IPO papers; eyes Rs 450 cr via fresh issue
Speciality chemicals company Safex Chemicals (India) has filed preliminary papers with the capital markets regulator Sebi to seek approval to raise funds through an initial public offering (IPO). The IPO is a mix of fresh issue of shares worth Rs 450 crore and an offer-for-sale of 35,734,818 shares by promoters, investors and other selling shareholders, according to the draft red herring prospectus (DRHP) filed on Thursday. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Earn Upto 5k Daily By This Method of Intraday Trading TradeWise Learn More Undo Proceeds from the fresh issue will be used for debt payment and general corporate purposes. Chrys Capital had invested in the company in March 2021 and September 2022, and owns 44.80 per cent of the equity share capital. Safex Chemicals may consider raising Rs 90 crore in a pre-IPO placement . If such placement is completed, the fresh issue size will be reduced. Live Events Incorporated in 1991, Safex Chemicals (India) operates in three business verticals --- branded formulations, speciality chemicals and contract development and manufacturing (CDMO). It serves farmers to help increase crop productivity by providing a wide range of crop protection products . The company has undertaken a series of acquisitions, as it bought Shogun Lifesciences in July 2021, Shogun Organics in September 2021 and Briar Chemicals in the UK in October 2022. As of March 31, 2025, the company had operations spread across 22 countries. It has seven manufacturing units in India and one in the United Kingdom. Safex Chemicals' revenue from operations increased by 12.83 per cent to Rs 1,584.78 crore in fiscal 2025 from Rs 1,404.59 crore in the preceding fiscal. Axis Capital , JM Financial and SBI Capital Markets are the book-running lead managers to the issue. Equity shares are proposed to be listed on the NSE and BSE. PTI
